| Management of patients with nephrotic syndrome. | |
| | |
MedLine Citation:
|
PMID: 19680831 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Nephrotic syndrome is characterised by proteinuria >3.5 g/24h, oedema, hypoalbuminaemia and hyperlipidaemia. Several glomerular diseases, either primary or secondary, may lead to nephrotic syndrome. Investigations for nephrotic syndrome include immunological and infectious evaluations. Renal biopsy is often mandatory, except in diabetes. Depending on aetiology specific treatment, often with immunosuppressive agents, may be implemented. In any cases nonspecific treatment should be started with ACE inhibitors or ARBs. Urinary protein loss leads to several complications: water and sodium retention, hyperlipidaemia, increased risk of thromboembolism and infection, anaemia and alteration of mineral metabolism. Each of these complications must be identified. |
| | |
Authors:
|
S de Seigneux; P Y Martin |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Swiss medical weekly Volume: 139 ISSN: 1424-7860 ISO Abbreviation: Swiss Med Wkly Publication Date: 2009 Jul |
Date Detail:
|
Created Date: 2009-08-14 Completed Date: 2009-10-08 Revised Date: 2011-02-15 |
Medline Journal Info:
|
Nlm Unique ID: 100970884 Medline TA: Swiss Med Wkly Country: Switzerland |
Other Details:
|
Languages: eng Pagination: 416-22 Citation Subset: IM |
Affiliation:
|
Service de Néphrologie, Département de médecine interne, HUG, Geneva, Switzerland. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Anemia
/
etiology Angiotensin II Type 1 Receptor Blockers / therapeutic use* Angiotensin-Converting Enzyme Inhibitors / therapeutic use* Dyslipidemias / etiology Edema / etiology Humans Hypertension / drug therapy, etiology Nephrotic Syndrome / complications, diagnosis, drug therapy* Thromboembolism / etiology |
| Chemical | |
Reg. No./Substance:
|
0/Angiotensin II Type 1 Receptor Blockers; 0/Angiotensin-Converting Enzyme Inhibitors |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Swiss clinical practice guidelines for skin cancer in organ transplant recipients.
Next Document: Emergency medicine training: a prospective, comparative study of an undergraduate clinical clerkship...